Hints and tips:
Related Special Reports
...The plan comes months after the launch of LillyDirect, which gave patients direct access to Lilly’s popular weight loss drug Zepbound, alongside 13 other products including migraine treatment Emgality....
...The first mental health treatment using schedule-1 drug MDMA faces a significant regulatory hurdle as the US Food and Drug Administration is poised to ask outside experts to scrutinise the treatment for...
...The first mental health treatment using schedule-1 drug MDMA faces a significant regulatory hurdle as the US Food and Drug Administration is poised to ask outside experts to scrutinise it for post-traumatic...
...Roche has cut a fifth of its drug pipeline in six months, shedding prospective cancer and neurology treatments as the Swiss company seeks to revitalise its business under new chief executive Thomas Schinecker...
...Merck has upped its profit and revenue guidance for this year as sales of its blockbuster cancer treatment Keytruda continue to surge....
...treatment of Alzheimer’s Alzheimer’s Disease affects a person’s neurons....
...Priced from £2,000 for three low-energy or one high-energy treatment, I advise to start with low energy and build up....
There is still room for growth in Japan’s $53bn dispensing pharmacy market
...New products revenue, which includes the weight loss treatments, came in at $2.39bn in the first quarter, up from $600mn during the same period last year....
...to cover the treatment....
...Investors’ interest in anti-obesity drugs sometimes seems all-consuming. Yet weight-loss treatments are not the only source of excitement in the world of pharmaceutical research....
...AstraZeneca has reported successful trial results for one of its top cancer drugs, in a boost to the drugmaker’s ambitions for its medication to be a treatment option for more than half of lung cancer patients...
...The approval of Madrigal’s drug should help other treatments to pass regulatory hurdles, according to analysts at investment bank William Blair....
...Both groups are studying the drugs as treatments for different types of fatty liver diseases....
...People who will receive treatment with Emblaveo will include very frail patients, those with severe infections or with few other treatment options, and those in regions where drug-resistant bacteria are...
...“Even in an expert treatment centre like ours, it requires a heavy lift in terms of resources and rallying the hospital system to implement these drugs,” said Prof Gil Rabinovici, a neurologist at San Francisco...
...Finding an effective treatment for Alzheimer’s has proved fiendishly difficult for drug companies, and previous regulatory decisions in the field have stirred controversy....
...AstraZeneca is withdrawing its Covid-19 vaccine less than four years after its UK launch after a “surplus” of drugs targeting newer variants led to sinking demand for the jab....
...After becoming the fastest drug ever to hit $1bn in annual sales, it was rapidly supplanted by a superior treatment from rival Gilead....
...AstraZeneca unveiled successes in the treatment of lung cancer on Monday, with its leading drug slowing progression of the disease at an early stage....
...Scotland approved the drug for advanced cancer treatment in December, creating a “heartbreaking postcode lottery of access”, the charity said....
...Whichever way, it all adds up to an expensive reminder of the long-odds lottery nature of drug development. Let’s hope it’s forgotten by the time the next pandemic arrives....
...Novo Nordisk is trialling GLP-1 treatments on conditions including cardiovascular diseases and Alzheimer’s, but the lixisenatide trial is one of the first longer studies to suggest that a GLP-1 drug may...
...Among the most expensive approved gene therapies are uniQure’s haemophilia B treatment Hemgenix, at $3.5mn and Bluebird’s thalassaemia drug Zynteglo, which is priced at $2.8mn....
International Edition